SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 7.20 |
Enterprise Value ($M) | -1.20 |
Book Value ($M) | 7.69 |
Book Value / Share | 0.48 |
Price / Book | 0.94 |
NCAV ($M) | 7.67 |
NCAV / Share | 0.48 |
Price / NCAV | 0.94 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.08 |
Return on Assets (ROA) | -1.86 |
Return on Equity (ROE) | -2.06 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 10.27 |
Current Ratio | 10.27 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 8.49 |
Assets | 8.52 |
Liabilities | 0.83 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -7.63 |
Net Income | -8.36 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -3.53 |
Cash from Investing | -0.00 |
Cash from Financing | 11.90 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Armistice Capital, Llc | 9.99 | ||
13G/A | Murphy John Raymond | 5.49 | 20.18 | |
13G | Pham Quang X | 48.57 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
21,405 | 62,394 | 34.31 | |
8,915 | 13,809 | 64.56 | |
45,570 | 30,081 | 151.49 | |
(click for more detail) |
Similar Companies | |
---|---|
CSBR – Champions Oncology, Inc. | CTXR – Citius Pharmaceuticals, Inc. |
CUE – Cue Biopharma, Inc. | CYCC – Cyclacel Pharmaceuticals, Inc. |
CYCN – Cyclerion Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io